Good Agreement Found for Clinical, Photograph Assessment of Psoriasis
THURSDAY, April 20, 2023 (HealthDay News) — There is good agreement between psoriasis severity assessed clinically and by photographs, according to a study recently published in JAAD International.Zarqa Ali, M.D., Ph.D., from Copenhagen University Ho…
Learn MoreGenetically Predicted Rheumatoid Arthritis Linked to Osteoporosis
THURSDAY, April 20, 2023 (HealthDay News) — Genetically predicted rheumatoid arthritis (RA) is associated with osteoporosis, according to a study published online April 11 in Arthritis & Rheumatology.Yunyang Deng and Martin Chi Sang Wong, M.D., from …
Learn MoreHealth Highlights: April 20, 2023
Simple test might spot early signs of Alzheimer’s. Using a ranking system, people who scored as a stage 3 or 4 risk were three times more likely to have thinking and memory issues later than those who scored as a 0 or 1. Read moreMany disabled or sing…
Learn MoreLa IA podría igualar al personal entrenado para detectar la TB en las radiografías de tórax
MARTES, 18 de abril de 2023 (HealthDay News) — La inteligencia artificial (IA) podría ayudar a los profesionales clínicos a diagnosticar la tuberculosis (TB) en partes del mundo donde los radiólogos escasean, sugiere un nuevo estudio.El software de I…
Learn MoreHealth Highlights: April 19, 2023
Is it time to end universal masking at hospitals? Many experts think so. Vaccines and treatments have made COVID more manageable, they say, and the latest strains do not produce as much life-threatening illness. Read moreDo you live in one of America’…
Learn MoreUna vacuna terapéutica contra el cáncer mejora la supervivencia de las personas con un melanoma avanzado
LUNES, 17 de abril de 2023 (HealthDay News) — Una vacuna experimental diseñada para dirigirse de forma específica a las células tumorales del melanoma de un paciente reduce significativamente las probabilidades de que el cáncer recurra, muestran los …
Learn MoreAACR: Adjuvant Atezolizumab + Bevacizumab Beneficial in Liver Cancer
TUESDAY, April 18, 2023 (HealthDay News) — For patients with high-risk hepatocellular carcinoma (HCC), adjuvant therapy of atezolizumab with bevacizumab (atezo + bev) prolongs recurrence-free survival, according to a study presented at the annual mee…
Learn MoreDigitally Reported Patient Outcomes Tied to Better Disease Control in RA
TUESDAY, April 18, 2023 (HealthDay News) — The use of a digital health application with patient-reported outcomes is associated with an increase in disease control rate for adults with rheumatoid arthritis (RA), according to a study published online …
Learn MoreSmartphone App May Help People Identify Smoking Triggers
TUESDAY, April 18, 2023 (HealthDay News) — A stop-smoking mobile app that senses where and when one might be triggered to smoke could help people quit, according to a study published online April 14 in Nicotine & Tobacco Research.Felix Naughton, Ph.D…
Learn MoreHearing Aids Might Help Lower Risk for Dementia
FRIDAY, April 14, 2023 (HealthDay News) — Can treating hearing loss lower your chances of developing dementia down the road?Maybe, claims new research that found that folks who are experiencing hearing loss and don’t use a hearing aid may have a high…
Learn More